binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings
Only IgG assay from top four in vitro diagnostic manufacturers that detects antibodies targeting the receptor binding domain on the spike protein
The partnership aims to provide accessible solutions for labs involved in COVID-19 testing
Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays
Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier
The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients
Mike Ludlow explains the dangers associated with nitrosamines and how his team protects people from overexposure to possible carcinogens found in medications
Reliable, easy-to-use cryo-EM workflow solution promises to quadruple throughput for pharma labs
The exciting new automated product is designed to harness the power of flow chemistry to deliver more compounds faster
The collaboration also includes the University of Coventry, UCB, and is supported by EIT Digital.
The company is providing well-characterized and standardized human primary cells with matching specialty cell culture media
Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs
These four viral infections have similar patient presentations, making accurate detection and differentiation critical during next flu season
Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology
The RECOVERY trial has shown that the cheap and widely available steroid cut deaths by one-third among patients critically ill with COVID-19
Join us on Tuesday, June 30, to find out how automated AQbD modeling can be used as a strategic approach across analytical operations of a large pharmaceutical company
It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.
Increase the effectiveness of human vaccines against infectious diseases such as COVID-19
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers
Company exploring further additional global capacity to provide broad and equitable access
llumina's COVIDSeq aims to generate information about the genomic sequence of the virus
Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide
Watch this on-demand webinar to discover how mass cytometry can be used to monitor immune responses to new therapeutics
LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients
The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications
